Abcam PLC operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abcam PLC with three other
pharmaceutical manufacturers in Europe:
Dottikon ES Holding AG
of SWITZERLAND
(2020
sales of 174.77 million Swiss Francs [US$188.13 million]
of which 100%
was The pharmaceutical),
Immunodiagnostic System HDQ
(£39.35 million [US$50.19 million]
of which 59%
was Automated), and
Allergy Therapeutics PLC
(£78.20 million [US$99.75 million]
).
Sales Analysis.
Abcam PLC reported sales of £260.00 million (US$331.63 million)
for the
fiscal
year ending
June of 2020.
This
represents
a very small
increase of 0.0%
versus 2019, when the company's sales were £259.90 million.
Sales at Abcam PLC have increased during each of the previous five years
(and since 2015, sales have increased a total of 81%).